FDA Clearance Tracker · P100047-S234
HeartWare® HVAD System
Last checked: Nov 20, 2026Latest source record: Feb 18, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 18, 2026
Approved
Time to decision
91 days
Received Nov 19, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
approval for design, manufacturing, and labeling changes to: (1) update the HVAD Controller design output specifications; (2) update manufacturing procedures to support the revised specifications; and (3) update labels and literature to reflect the new Ingress Protection (IP) Rating for the HVAD Controller.
Source documents
Other decisions for Medtronic
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262716 · Decided Nov 6, 2026 · 98 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.